Morphine Sulfate Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

morphine sulfate

medsurge pharma limited - morphine sulfate pentahydrate 10 mg/ml;   - solution for injection - 10 mg/ml - active: morphine sulfate pentahydrate 10 mg/ml   excipient: hydrochloric acid nitrogen sodium chloride water for injection - the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Morphine Sulfate Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

morphine sulfate

medsurge pharma limited - morphine sulfate pentahydrate 2 mg/ml;   - solution for injection - 2 mg/ml - active: morphine sulfate pentahydrate 2 mg/ml   excipient: hydrochloric acid nitrogen sodium chloride water for injection - the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Morphine Sulfate Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

morphine sulfate

medsurge pharma limited - morphine sulfate pentahydrate 30 mg/ml;   - solution for injection - 30 mg/ml - active: morphine sulfate pentahydrate 30 mg/ml   excipient: hydrochloric acid nitrogen sodium chloride water for injection - the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

PMS-MORPHINE SULFATE SR 15 MG TABLET (EXTENDED-RELEASE) Kanada - Englisch - Health Canada

pms-morphine sulfate sr 15 mg tablet (extended-release)

pharmascience inc - morphine sulfate - tablet (extended-release) - 15mg - morphine sulfate 15mg - opiate agonists

MORPHINE SULFATE EXTENDED-RELEASE- morphine sulfate tablet, extended release Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

morphine sulfate extended-release- morphine sulfate tablet, extended release

stat rx usa llc - morphine sulfate (unii: x3p646a2j0) (morphine - unii:76i7g6d29c) - morphine sulfate 15 mg - morphine sulfate extended-release tablets are an extended-release oral formulation of morphine sulfate indicated for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. morphine sulfate extended-release tablets are not intended for use as a prn analgesic. the morphine sulfate extended-release tablets 100 mg and 200 mg strengths are high dose, extended-release, oral morphine formulations indicated for the relief of pain in opioid-tolerant patients only. morphine sulfate extended-release tablets are not indicated for pain in the immediate postoperative period (the first 12 to 24 hours following surgery) for patients not previously taking the drug, because its safety in this setting has not been established. morphine sulfate extended-release tablets are not indicated for pain in the postoperative period if the pain is mild, or not expected to persist for an extended period of time. morphine sulfate extended-release tablets are o

MORPHINE SULFATE- morphine sulfate  injection Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

morphine sulfate- morphine sulfate injection

international medication systems, limited - morphine sulfate (unii: x3p646a2j0) (morphine - unii:76i7g6d29c) - morphine sulfate 1 mg in 1 ml - morphine sulfate is indicated for the relief of severe pain. it is used preoperatively to sedate the patient and allay apprehension, facilitate anesthesia induction and reduce anesthetic dosage. it is likewise effective in the control of postoperative pain. the use of morphine for the relief of pain should be reserved for the more severe manifestations of pain, as in myocardial infarction,severe injuries, or in severe chronic pain associated with terminal cancer after all non-narcotic analgesics have failed. effective analgesic therapy of severe chronic pain associated with terminal cancer continues to be a difficult problem. intermittent administration of intramuscular morphine may be effective; however, the mode of therapy has significant limitations. morphine has a short plasma half-life of 2.5 to 3.0 hours; therefore, frequent administration (every 1 to 2 hours) often becomes necessary to control severe pain associated with cancer. tolerance develops to the analgesic effects and increasingly higher doses

DBL MORPHINE SULFATE 30mg/1mL injection ampoule Australien - Englisch - Department of Health (Therapeutic Goods Administration)

dbl morphine sulfate 30mg/1ml injection ampoule

pfizer australia pty ltd - morphine sulfate pentahydrate, quantity: 30 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride - indications as at 7 july 2020: dbl morphine sulfate injection is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. dbl morphine sulfate injection may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

DBL MORPHINE SULFATE 15mg/1mL injection ampoule Australien - Englisch - Department of Health (Therapeutic Goods Administration)

dbl morphine sulfate 15mg/1ml injection ampoule

pfizer australia pty ltd - morphine sulfate pentahydrate, quantity: 15 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - indications as at 7 july 2020: dbl morphine sulfate injection is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. dbl morphine sulfate injection may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

DBL MORPHINE SULFATE 10mg/1mL injection ampoule Australien - Englisch - Department of Health (Therapeutic Goods Administration)

dbl morphine sulfate 10mg/1ml injection ampoule

pfizer australia pty ltd - morphine sulfate pentahydrate, quantity: 10 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - indications as at 7 july 2020: dbl morphine sulfate injection is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. dbl morphine sulfate injection may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MORPHINE SULFATE INJECTION USP SOLUTION Kanada - Englisch - Health Canada

morphine sulfate injection usp solution

icu medical canada inc - morphine sulfate - solution - 5mg - morphine sulfate 5mg - opiate agonists